Epidemiology, Pathophysiology, and Pharmacological Status of Asthma
Current Respiratory Medicine Reviews
; 18(4):247-258, 2022.
Article
in English
| EMBASE | ID: covidwho-2197747
ABSTRACT
In India, asthma is a prevalent respiratory condition marked by frequent blowouts and a distinctive spread pattern. Respiratory diseases are the main cause of death globally. In India, asthma is more common, particularly in the North Indian states of Delhi and Uttar Pradesh. Our primary objective in this review is to study asthma medication therapy and its associated complications. The epidemiology, etiology, pathophysiology, mechanism of airway inflammation, classification, and diagnosis of asthma are all illustrated in the current work. Additionally, we have gathered state-by-state information on asthma for the last five years in Northern India. Asthma diagnosis and management are also discussed in accordance with the guidelines of many agencies, including NICE, BTS, SIGN, and WHO. Copyright © 2022 Bentham Science Publishers.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Observational study
Language:
English
Journal:
Current Respiratory Medicine Reviews
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS